SBFM SCHEDULE 13G: SEC filing

CVI Investments, Inc. and Heights Capital Management, Inc.

Filed with the SEC on Oct 13, 2026 · accession 0001649553-26-000116

SBFM filed a SCHEDULE 13G (schedule 13g) with the SEC on Oct 13, 2026. CVI Investments, Inc. and Heights Capital Management, Inc. filed a joint Schedule 13G disclosing beneficial ownership of Sunshine Biopharma Inc. common stock. The stock moved -21.8% by the first close after the filing.

Summary of the filing

CVI Investments, Inc. and Heights Capital Management, Inc. filed a joint Schedule 13G disclosing beneficial ownership of Sunshine Biopharma Inc. common stock. The filing is a passive ownership disclosure under Rule 13d-1(k).

For details, click here →

Key details

Reporting person / beneficial ownerCVI Investments, Inc.

Reporting person / investment managerHeights Capital Management, Inc.

IssuerSunshine Biopharma Inc.

Assistant general counsel and assistant secretarySarah Travis

How SBFM stock reacted

Close before

$6.04

Oct 12, 2026

First close after

-21.75%

$4.73

5 trading days

-19.93%

$4.84

Since filing

-55.13%

$2.71

✦ Ask GOAX AI about this filing — what it means for SBFM, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for SBFM?

Click here

Frequently asked questions

What did SBFM file with the SEC on Oct 13, 2026?

SBFM filed a SCHEDULE 13G (SEC filing). CVI Investments, Inc. and Heights Capital Management, Inc. filed a joint Schedule 13G disclosing beneficial ownership of Sunshine Biopharma Inc. common stock. The filing is a passive ownership disclosure under Rule 13d-1(k).

How do I read a SCHEDULE 13G?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).

How did SBFM stock react to this filing?

SBFM closed at $6.04 before the filing and $4.73 on Oct 13, 2026 (-21.75%). Five trading days later: $4.84 (-19.93%).

Other SBFM SEC filings

Get alerts when SBFM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

SBFM overview SBFM analysis SBFM news Latest SEC filings